Literature DB >> 6771070

Antibodies to extractable nuclear antigens in rheumatoid arthritis: relationship to vasculitis and circulating immune complexes.

P J Venables, C C Erhardt, R N Maini.   

Abstract

Antibodies to extractable nuclear antigens (ENA) were analysed in the sera of fifty-two patients with severe rheumatoid arthritis (RA) who were divided into two categories: twenty-five with arthritis only and twenty-seven with extra-articular disease. Using haemagglutination, counterimmunoelectropheresis (CIE) and double diffusion, antibodies to ENA were detected in three (12%) of the patients with arthritis only. In the group with extra-articular disease, antibodies were found in sixteen (59%) of the patients. In ten patients the antibodies reacted with an RNase and DNAse resistant, but trypsin sensitive protein component of ENA. These patients all had extraarticular disease with digital vasculitis being a particularly common feature. Their sera also contained circulating immune complexes detected by elevated cryoprecipitate protein levels associated with relatively low complement levels. It is suggested that antibodies to soluble proteins of nuclear origin may be markers of circulating immune complexes in extra-articular RA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771070      PMCID: PMC1537954     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence.

Authors:  M A Aslpaugh; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

2.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

3.  Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome.

Authors:  M A Alspaugh; N Talal; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

4.  Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera.

Authors:  M Mattioli; M Reichlin
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

5.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

6.  Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Authors:  G C Sharp; W S Irvin; C M May; H R Holman; F C McDuffie; E V Hess; F R Schmid
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

7.  Antinuclear antibody with distinct specificity for polymyositis.

Authors:  J F Wolfe; E Adelstein; G C Sharp
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Antibodies to cellular antigens in Sjögren's syndrome.

Authors:  M A Alspaugh; E M Tan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

9.  Characteristics of patients with serum antibodies to extractable nuclear antigens.

Authors:  J H Leibfarth; R H Persellin
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

10.  Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.

Authors:  G C Sharp; W S Irvin; R L LaRoque; C Velez; V Daly; A D Kaiser; H R Holman
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

View more
  19 in total

1.  Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides.

Authors:  D G Williams; M R Stocks; P R Smith; R N Maini
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

Review 2.  Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis.

Authors:  P Venables
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

3.  Rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

4.  Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies.

Authors:  M A French; G Harrison; C A Penning; J Cunningham; P Hughes; N R Rowell
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

5.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.

Authors:  C C Erhardt; P Mumford; R N Maini
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

7.  Precipitating antibodies to nuclear antigens in systemic vasculitis.

Authors:  D G Scott; R P Skinner; P A Bacon; P J Maddison
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

8.  Chronic active hepatitis with high level of anti-ds-DNA detected by a solid phase radioimmunoassay.

Authors:  A Peretz; F Mascart-Lemone; G Nuttin; J P Famaey
Journal:  Clin Rheumatol       Date:  1982-09       Impact factor: 2.980

9.  Purification and characterization of the Sjögren's syndrome A and B antigens.

Authors:  P J Venables; P R Smith; R N Maini
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

10.  IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.

Authors:  F P Quismorio; T Beardmore; R L Kaufman; E S Mongan
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.